Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia
โ Scribed by Jan Styczynski; Mariusz Wysocki; Robert Debski; Krzysztof Czyzewski; Beata Kolodziej; Beata Rafinska; Malgorzata Kubicka; Sylwia Koltan; Andrzej Koltan; Monika Pogorzala; Andrzej Kurylak; Dorota Olszewska-Slonina; Walentyna Balwierz; Edyta Juraszewska; Maria Wieczorek; Igor Olejnik; Maryna Krawczuk-Rybak; Marta Kuzmicz; Jerzy Kowalczyk; Jolanta Stefaniak; Wanda Badowska; Danuta Sonta-Jakimczyk; Tomasz Szczepanski; Michal Matysiak; Iwona Malinowska; Elzbieta Stanczak; Jacek Wachowiak; Benigna Konatkowska; Lidia Gil; Anna Balcerska; Lucyna Maciejka-Kapuscinska
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 85 KB
- Volume
- 133
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Blast cells of 71 children with newly diagnosed acute lymphoโblastic leukemia (ALL) were examined with a novel monoclonal antibody (MAb), Sโ44, immunoreactive to statin, a nuclear protein specifically expressed in nonโproliferating cells. The statin labeling index (LI) varied greatly fr
## Abstract Nowadays about twoโthirds of children with acute lymphoblastic leukemia (ALL) can be cured with chemotherapy, but oneโthird die from the disease. The clinical response of leukemic cells to chemotherapy is roughly due to two factors: the effective drug levels reaching the cells and the r